BSEM

$1.17+1.74%visit website

BIOSTEM TECHNOLOGIES

Market Cap

$78M

Finnhub, as of 2026-09-18

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

0.66

60mo monthly vs SPY

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Jun 2025 Jun 30, 2025	Q2 FY2026 Jun 30, 2026
Revenue	10,963	7,899
Cost of revenue	685	3,059
Gross profit	10,278	4,841
Research & development	1,957	734
Total operating expenses	10,165	13,241
Operating income	113	(8,401)
Pretax income	178	(8,971)
Income tax	167	0
Net income	11	(8,971)
EPS (basic) ($)	0.00	(0.52)
EPS (diluted) ($)	0.00	(0.52)
Weighted avg. shares (basic)	16,709	17,328
Weighted avg. shares (diluted)	23,420	17,328

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 12, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source